Accueil / Formation Recherche / Publications / Publications Mastocytoses

Publications Mastocytoses

Topical pimecrolimus for paediatric cutaneous mastocytosis. Mashiah J et al. Clin Exp Dermatol. 2018 Feb 20.

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis. Scheeweiss M et al. Haematologica. 2018 Feb 8. 

A "foamy" mastocytosis case. Kim et al. Blood. 2018 Feb 1.

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells. MedPeter B et al. Leukemia. 2018 Apr.

Midostaurin: a magic bullet that blocks mast cell expansion and activation. Valent P et al. Ann Oncol. 2017 Oct 1;28(10):2367-2376

Prevalence and risk factors for fragility fracture in systemic mastocytosis. Degboé Y et al. Bone. 2017 Sep 14;105:219-225.

Neuroimaging evidence of brain abnormalities in mastocytosis. Boddaert N et al. Transl Psychiatry. 2017 Aug 8;7(8):e1197

Targeted Treatment Options in Mastocytosis. Vaes M et al. Front Med (Lausanne). 2017 Jul 20;4:110.

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.
 
A French National Survey on Clotting Disorders in Mastocytosis.
 
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.
 
Current treatment options in patients with mastocytosis: status in 2015 and future perspectives.
 
Isolated flushes without permanent, fixed or other skin lesions in patients with systemic mastocytosis: a case series of 9 patients.
 
Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms.
 
Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.
 
FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.

 

ACTUALITÉS

Le Pr Eric Oksenhendler récompensé "Médecin de l'année 2018" pour son travail sur la maladie de Castleman

Calendrier 2019 de la filière MaRIH disponible !
Téléchargez le nouveau calendrier avec les dates de la filière, des centres de référence, des associations de patients et des sociétés savantes
Nouveau cas clinique "Amylose AL"
Testez vos connaissances
Voir toutes les actualités

AGENDA

Du 24-01-2019 au 25-01-2019 : Congrès de la Société d'Hématologie et d'Immunologie Pédiatrique, Chamonix


25-01-2019 : 5ème Journée Maladies Rares Hématologie - Médecine Interne, Paris


01-02-2019 : Journée annuelle du centre de référence de l'amylose AL et autres maladies par dépôt d'immunoglobulines monoclonales, Paris
Voir tout l'agenda